|
Rebrov A.P.,Kuklina A.L.
Renal function parameters and endothelial disfunction in patients with arterial hypertension
|
№5-6 / 2012
|
|
Burmagina A.G., Nikolaev A.Yu.
Association of prehypertension with risk factors of chronic kidney disease, arterial hypertension and atherosclerosis
|
№5-6 / 2012
|
|
Rogova I.V., Fomin V.V. , Damulin I.V. ,.Mukhin N.A.
Mild cognitive disorders in chronic kidney disease: clinical spectrum, pathogenesis, risk factors, treatment
|
№5-6 / 2012
|
|
V.V. Fomin
Role of iron sucrose in treatment of anemia in chronic kidney disease
|
№4 / 2012
|
|
E.M. Shilov
Hyperphosphatemia correction in chronic kidney disease: role of sevelamer
|
№4 / 2012
|
|
A.A. Plotnikova, L.Yu. Milovanova, Yu.S. Milovanov
Paricalcitol – new opportunities in nephroprotection and treatment of secondary hyperparathyreosis
|
№4 / 2012
|
|
A.N. Fedoseev, A.S. Kudriakova, V.V. Smirnov, T.A. Krutova, K.V. Ovsiannikov
Ace inhibitors in endothelial dysfunction correction in patients with c chronic kidney disease
|
№4 / 2012
|
|
O.N. Kurochkina
Determination of renal function with glomerular filtration rate parameter in ambulatory practice
|
№4 / 2012
|
|
M.M. Batiushin, A.A. Gaushkin, V.N. Poganeva, E.G. Asrumian, A.S. Litvinov, N.A. Sadovnichaya, D.S. Tsevtskov, L.I. Rudenko
Sulodexide (“Vessel Due F”) – new perspectives in nephroprotecive therapy
|
№3 / 2012
|
|
N.A. Mukhin, L.A. Alekseeva, V.S. Babanin, E.D. Dokina, L.O. Minushkina
Renal function and heart valve calcification in postmenopausal women
|
№3 / 2012
|
|
V.V. Kaliuzhin, O.F. Sibirtseva, O.I. Urazova, E.V. Kaliuzhina, L.M. Tkalich, Li.I. Zibnitskaya, R.N. Kolesnikov, V.Yu. Grankina
Laboratory markers of haemosthasis panel in prognosing of progression of chronic kidney disease
|
№3 / 2012
|
|
A.P. Rebrov, O.G. Kargalskaya
Prevalence of chronic kidney disease in patients with psoriatic arthritis
|
№3 / 2012
|
Русский
